HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vinflunine: a new microtubule inhibitor agent.

Abstract
Vinflunine (Javlor) is the first fluorinated microtubule inhibitor belonging to the Vinca alkaloids family. Vinflunine is obtained by semisynthesis using superacidic chemistry to selectively introduce two fluorine atoms at the 20' position of the catharanthine moiety. This compound has been selected for clinical development on the basis of encouraging preclinical activity that warrants study in patients with a wide spectrum of solid tumors. Clinically significant activity has been seen in phase II studies, mainly in the treatment of transitional cell carcinoma of the urothelial tract, non-small cell lung cancer, and carcinoma of the breast. Vinflunine is currently in phase III trial assessment in patients with (second line) transitional cell carcinoma of the urothelium and first-line advanced breast cancer. The efficacy of vinflunine in patients with advanced non-small cell lung cancer previously treated with a platinum-containing regimen was confirmed by a large phase III trial.
AuthorsJaafar Bennouna, Jean-Pierre Delord, Mario Campone, Laurent Nguyen
JournalClinical cancer research : an official journal of the American Association for Cancer Research (Clin Cancer Res) Vol. 14 Issue 6 Pg. 1625-32 (Mar 15 2008) ISSN: 1078-0432 [Print] United States
PMID18347163 (Publication Type: Journal Article, Review)
Chemical References
  • Tubulin Modulators
  • vinflunine
  • Vinblastine
Topics
  • Animals
  • Breast Neoplasms (drug therapy)
  • Carcinoma (drug therapy)
  • Carcinoma, Transitional Cell (drug therapy, pathology)
  • Clinical Trials as Topic
  • Drug Evaluation, Preclinical
  • Humans
  • Lung Neoplasms (drug therapy)
  • Models, Biological
  • Neoplasms (drug therapy, metabolism)
  • Treatment Outcome
  • Tubulin Modulators (adverse effects, pharmacokinetics, therapeutic use)
  • Urologic Neoplasms (drug therapy, pathology)
  • Urothelium (pathology)
  • Vinblastine (adverse effects, analogs & derivatives, pharmacokinetics, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: